[rt-PA versus streptokinase--Has the controversy regarding the optimal thrombolytic agent been resolved by results of the GISSI II/International rt-PA vs. Streptokinase fatality Study?]

Z Kardiol. 1991 Jan;80(1):1-5.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Plasminogen Activators / administration & dosage*
  • Plasminogen Activators / adverse effects
  • Product Surveillance, Postmarketing*
  • Recurrence
  • Streptokinase / administration & dosage*
  • Streptokinase / adverse effects
  • Survival Rate

Substances

  • Streptokinase
  • Plasminogen Activators